
Glenmark Pharma Share Price in 2025: Chart, Monthly Trends, & Analysis


How did Glenmark Pharma shares perform in 2025?
Let's find out!
Glenmark Pharma share price in 2025 was ₹1,860.1 Its price on 1st January 2025 was ₹1,609.1, and by 31st December 2025 it moved to ₹1,860.1, giving a positive return of 15.59% for the year.
Glenmark Pharma Share Open, High, Low, and Close prices for the Year 2025 are as follows:
Open | High | Low | Close |
---|---|---|---|
₹1,609.1 | ₹1,879.4 | ₹1,275.5 | ₹1,860.1 |
1st Jan 2025 | Occured in Jul 2025 | Occured in Feb 2025 | 31st Dec 2025 |
This page will help you understand how Glenmark Pharma performed in 2025. Let's get started.
For complete insights into Glenmark Pharma’s incredible stock price performance and growth, see: Glenmark Pharma Historical Share Price Data from its IPO to 2025
Table: Glenmark Pharma Share Monthly Close, Low, High Prices for 2025
Month | Glenmark Pharma | Change% | ↑High - ↓Low |
---|---|---|---|
Jan | ₹1,453.2 | - |
↑ ₹1,658 ↓ ₹1,368.15 |
Feb | ₹1,278.95 | -12% |
↑ ₹1,553.4 ↓ ₹1,275.5 |
Mar | ₹1,541.05 | 20.4% |
↑ ₹1,546.4 ↓ ₹1,277.3 |
Apr | ₹1,381.2 | -10.4% |
↑ ₹1,582.95 ↓ ₹1,336 |
May | ₹1,457.1 | 5.4% |
↑ ₹1,471.1 ↓ ₹1,355.4 |
Jun | ₹1,753.8 | 20.3% |
↑ ₹1,758.2 ↓ ₹1,448.5 |
Jul | ₹1,860.1 | 6% |
↑ ₹1,879.4 ↓ ₹1,740.1 |
Chart: CandleStick and Line Chart Showing Monthly Prices
[Click on line name to show/hide a line]
What if You invested ₹10,000 in Glenmark Pharma in 2025?
In 2025, the opening price of Glenmark Pharma share was ₹1609.10. Today, the price stands at ₹1,830.5, reflecting a growth of 13.75%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2025 would have become ₹11,375.92 by 2025. This represents a CAGR of 13.76%.
You might also like to check: Glenmark Pharma Stock Price in 2024
References:
Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.
Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.